TR200102648T2 - Büyümeyi destekleyen bileşimler - Google Patents
Büyümeyi destekleyen bileşimlerInfo
- Publication number
- TR200102648T2 TR200102648T2 TR2001/02648T TR200102648T TR200102648T2 TR 200102648 T2 TR200102648 T2 TR 200102648T2 TR 2001/02648 T TR2001/02648 T TR 2001/02648T TR 200102648 T TR200102648 T TR 200102648T TR 200102648 T2 TR200102648 T2 TR 200102648T2
- Authority
- TR
- Turkey
- Prior art keywords
- compositions
- support growth
- inhibitors
- growth
- regrowth
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Pyrrole Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Dipeptidil peptidaz IV inhibitörleri ve bu inhibitörleri ihtiva eden farmasötik bilesimler büyüme hormonu eksikligine bagli boy kisaliginin tedavisinde ve BH'ye bagimli doku büyümesinin veya yeniden büyümesinin desteklenmesi için faydalidirlar.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9906715.9A GB9906715D0 (en) | 1999-03-23 | 1999-03-23 | Compositions for promoting growth |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200102648T2 true TR200102648T2 (tr) | 2001-12-21 |
Family
ID=10850230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/02648T TR200102648T2 (tr) | 1999-03-23 | 2000-03-21 | Büyümeyi destekleyen bileşimler |
Country Status (26)
Country | Link |
---|---|
US (1) | US6521644B1 (tr) |
EP (1) | EP1171121B1 (tr) |
JP (1) | JP2002539244A (tr) |
KR (1) | KR100704348B1 (tr) |
CN (1) | CN1359293A (tr) |
AR (1) | AR023130A1 (tr) |
AT (1) | ATE297728T1 (tr) |
AU (1) | AU772421B2 (tr) |
CA (1) | CA2366926A1 (tr) |
CZ (1) | CZ20013411A3 (tr) |
DE (1) | DE60020825T2 (tr) |
GB (1) | GB9906715D0 (tr) |
HK (1) | HK1048589A1 (tr) |
HU (1) | HUP0200391A3 (tr) |
IL (2) | IL145568A0 (tr) |
MX (1) | MXPA01009610A (tr) |
MY (1) | MY124214A (tr) |
NO (1) | NO20014608L (tr) |
NZ (1) | NZ514450A (tr) |
PL (1) | PL195529B1 (tr) |
RU (1) | RU2242228C2 (tr) |
TR (1) | TR200102648T2 (tr) |
TW (1) | TWI239246B (tr) |
UA (1) | UA73115C2 (tr) |
WO (1) | WO2000056297A2 (tr) |
ZA (1) | ZA200108082B (tr) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040152745A1 (en) * | 1999-11-12 | 2004-08-05 | Guilford Pharmaceuticals, Inc. | Dipeptidyl peptidase IV inhibitors and methods of making and using dipeptidyl peptidase IV inhibitors |
GB9928330D0 (en) * | 1999-11-30 | 2000-01-26 | Ferring Bv | Novel antidiabetic agents |
US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
DE60223920T2 (de) * | 2001-06-27 | 2008-11-13 | Smithkline Beecham Corp. | Pyrrolidine als dipeptidyl-peptidase-inhibitoren |
UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
US7309714B2 (en) * | 2002-12-04 | 2007-12-18 | Merck & Co., Inc. | Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
US20040242568A1 (en) * | 2003-03-25 | 2004-12-02 | Syrrx, Inc. | Dipeptidyl peptidase inhibitors |
WO2004103993A1 (en) | 2003-05-14 | 2004-12-02 | Syrrx, Inc. | Dipeptidyl peptidase inhibitors |
US7790736B2 (en) * | 2003-08-13 | 2010-09-07 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7678909B1 (en) | 2003-08-13 | 2010-03-16 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7169926B1 (en) | 2003-08-13 | 2007-01-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
JP2007513058A (ja) * | 2003-09-08 | 2007-05-24 | 武田薬品工業株式会社 | ジペプチジルぺプチダーゼ阻害剤 |
US7790734B2 (en) * | 2003-09-08 | 2010-09-07 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7732446B1 (en) | 2004-03-11 | 2010-06-08 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
CN102134229B (zh) * | 2004-03-15 | 2020-08-04 | 武田药品工业株式会社 | 二肽基肽酶抑制剂 |
WO2005118555A1 (en) * | 2004-06-04 | 2005-12-15 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
WO2006019965A2 (en) | 2004-07-16 | 2006-02-23 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
WO2006068978A2 (en) * | 2004-12-21 | 2006-06-29 | Takeda Pharmaceutial Company Limited | Dipeptidyl peptidase inhibitors |
DOP2006000008A (es) | 2005-01-10 | 2006-08-31 | Arena Pharm Inc | Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1 |
ZA200708179B (en) * | 2005-04-22 | 2009-12-30 | Alantos Pharmaceuticals Holding Inc | Dipeptidyl peptidase-IV inhibitors |
PL1942898T5 (pl) | 2005-09-14 | 2014-10-31 | Takeda Pharmaceuticals Co | Inhibitory peptydazy dipeptydylowej do leczenia cukrzycy |
KR101352588B1 (ko) * | 2005-09-14 | 2014-01-17 | 다케다 야쿠힌 고교 가부시키가이샤 | 당뇨병 치료용 디펩티딜 펩티다아제 억제제 |
US20070060529A1 (en) * | 2005-09-14 | 2007-03-15 | Christopher Ronald J | Administration of dipeptidyl peptidase inhibitors |
TW200745080A (en) * | 2005-09-16 | 2007-12-16 | Takeda Pharmaceuticals Co | Polymorphs of tartrate salt of 2-[2-(3-(R)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6H-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor |
TW200745079A (en) * | 2005-09-16 | 2007-12-16 | Takeda Pharmaceuticals Co | Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
CN102675221A (zh) | 2005-09-16 | 2012-09-19 | 武田药品工业株式会社 | 用于制备嘧啶二酮衍生物的方法中的中间体 |
WO2007112347A1 (en) | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
WO2007112368A1 (en) * | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Preparation of (r)-3-aminopiperidine dihydrochloride |
PE20071221A1 (es) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
GEP20125701B (en) * | 2006-09-13 | 2012-12-10 | Takeda Pharmaceuticals Co | Application of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile |
US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
EP2108960A1 (en) | 2008-04-07 | 2009-10-14 | Arena Pharmaceuticals, Inc. | Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY |
JO2870B1 (en) | 2008-11-13 | 2015-03-15 | ميرك شارب اند دوهم كورب | Amino Tetra Hydro Pirans as Inhibitors of Peptide Dipeptide IV for the Treatment or Prevention of Diabetes |
AR077642A1 (es) | 2009-07-09 | 2011-09-14 | Arena Pharm Inc | Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo |
RU2550508C2 (ru) | 2009-09-02 | 2015-05-10 | Мерк Шарп И Доум Корп. | Аминотетрагидропираны в качестве ингибиторов дипептидилпептидазы-iv для лечения или предупреждения диабета |
US8648073B2 (en) | 2009-12-30 | 2014-02-11 | Fochon Pharma, Inc. | Certain dipeptidyl peptidase inhibitors |
EP2538783B1 (en) | 2010-02-22 | 2016-06-01 | Merck Sharp & Dohme Corp. | Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes |
MX2012011631A (es) | 2010-04-06 | 2013-01-18 | Arena Pharm Inc | Moduladores del receptor gpr119 y el tratamiento de trastornos relacionados con el mismo. |
WO2011146358A1 (en) | 2010-05-21 | 2011-11-24 | Merck Sharp & Dohme Corp. | Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes |
BR112013008100A2 (pt) | 2010-09-22 | 2016-08-09 | Arena Pharm Inc | "moduladores do receptor de gpr19 e o tratamento de distúrbios relacionados a eles." |
US20140018371A1 (en) | 2011-04-01 | 2014-01-16 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
WO2012145361A1 (en) | 2011-04-19 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145603A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145604A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2013055910A1 (en) | 2011-10-12 | 2013-04-18 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
US9073930B2 (en) | 2012-02-17 | 2015-07-07 | Merck Sharp & Dohme | Dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
WO2014018350A1 (en) | 2012-07-23 | 2014-01-30 | Merck Sharp & Dohme Corp. | Treating diabetes with dipeptidyl peptidase-iv inhibitors |
WO2014074668A1 (en) | 2012-11-08 | 2014-05-15 | Arena Pharmaceuticals, Inc. | Modulators of gpr119 and the treatment of disorders related thereto |
CA2979033A1 (en) | 2015-03-09 | 2016-09-15 | Intekrin Therapeutics, Inc. | Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy |
US11253508B2 (en) | 2017-04-03 | 2022-02-22 | Coherus Biosciences, Inc. | PPARy agonist for treatment of progressive supranuclear palsy |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE148130T1 (de) | 1990-04-14 | 1997-02-15 | New England Medical Center Inc | Typ-iv-dipeptidyl-aminopeptidase-inhibitoren |
SK49093A3 (en) * | 1990-11-14 | 1993-10-06 | Upjohn Co | Stabilized active analogues of factors releasing of growth hormone |
JPH0543453A (ja) * | 1991-08-20 | 1993-02-23 | Sumitomo Pharmaceut Co Ltd | 創傷治癒促進用局所用徐放性製剤 |
HUT67319A (en) * | 1991-08-30 | 1995-03-28 | Life Medical Sciences Inc | Compositions for treating wounds |
EP0610317B1 (en) * | 1991-10-22 | 2001-01-31 | New England Medical Center Hospitals, Inc. | Inhibitors of dipeptidyl-aminopeptidase type iv |
IL111785A0 (en) * | 1993-12-03 | 1995-01-24 | Ferring Bv | Dp-iv inhibitors and pharmaceutical compositions containing them |
JPH09295946A (ja) * | 1995-05-16 | 1997-11-18 | Mitsui Pharmaceut Inc | 医薬組成物 |
JPH09308259A (ja) * | 1996-05-17 | 1997-11-28 | Toshiba Lighting & Technol Corp | 電源装置、放電ランプ点灯装置及び照明装置 |
TW492957B (en) | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
US5952301A (en) | 1996-12-10 | 1999-09-14 | 1149336 Ontario Inc. | Compositions and methods for enhancing intestinal function |
-
1999
- 1999-03-23 GB GBGB9906715.9A patent/GB9906715D0/en not_active Ceased
-
2000
- 2000-03-21 CZ CZ20013411A patent/CZ20013411A3/cs unknown
- 2000-03-21 EP EP00911195A patent/EP1171121B1/en not_active Expired - Lifetime
- 2000-03-21 CN CN00805326A patent/CN1359293A/zh active Pending
- 2000-03-21 JP JP2000606202A patent/JP2002539244A/ja active Pending
- 2000-03-21 AU AU33186/00A patent/AU772421B2/en not_active Ceased
- 2000-03-21 WO PCT/IB2000/000393 patent/WO2000056297A2/en not_active Application Discontinuation
- 2000-03-21 HU HU0200391A patent/HUP0200391A3/hu unknown
- 2000-03-21 TR TR2001/02648T patent/TR200102648T2/tr unknown
- 2000-03-21 AT AT00911195T patent/ATE297728T1/de not_active IP Right Cessation
- 2000-03-21 DE DE60020825T patent/DE60020825T2/de not_active Expired - Fee Related
- 2000-03-21 US US09/937,031 patent/US6521644B1/en not_active Expired - Fee Related
- 2000-03-21 NZ NZ514450A patent/NZ514450A/xx unknown
- 2000-03-21 IL IL14556800A patent/IL145568A0/xx active IP Right Grant
- 2000-03-21 RU RU2001128504/15A patent/RU2242228C2/ru not_active IP Right Cessation
- 2000-03-21 KR KR1020017012145A patent/KR100704348B1/ko not_active IP Right Cessation
- 2000-03-21 MX MXPA01009610A patent/MXPA01009610A/es active IP Right Grant
- 2000-03-21 UA UA2001096487A patent/UA73115C2/uk unknown
- 2000-03-21 MY MYPI20001117A patent/MY124214A/en unknown
- 2000-03-21 CA CA002366926A patent/CA2366926A1/en not_active Abandoned
- 2000-03-21 PL PL00350796A patent/PL195529B1/pl unknown
- 2000-03-22 AR ARP000101281A patent/AR023130A1/es unknown
- 2000-03-23 TW TW089105321A patent/TWI239246B/zh not_active IP Right Cessation
-
2001
- 2001-09-21 NO NO20014608A patent/NO20014608L/no not_active Application Discontinuation
- 2001-09-23 IL IL145568A patent/IL145568A/en unknown
- 2001-10-02 ZA ZA200108082A patent/ZA200108082B/xx unknown
-
2002
- 2002-11-29 HK HK02108644.1A patent/HK1048589A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
NZ514450A (en) | 2002-11-26 |
IL145568A0 (en) | 2002-06-30 |
DE60020825D1 (de) | 2005-07-21 |
CN1359293A (zh) | 2002-07-17 |
HUP0200391A2 (en) | 2002-06-29 |
KR100704348B1 (ko) | 2007-04-05 |
MXPA01009610A (es) | 2002-07-02 |
NO20014608L (no) | 2001-10-31 |
ZA200108082B (en) | 2002-12-24 |
ATE297728T1 (de) | 2005-07-15 |
RU2242228C2 (ru) | 2004-12-20 |
JP2002539244A (ja) | 2002-11-19 |
DE60020825T2 (de) | 2006-05-04 |
MY124214A (en) | 2006-06-30 |
WO2000056297A2 (en) | 2000-09-28 |
TWI239246B (en) | 2005-09-11 |
EP1171121A2 (en) | 2002-01-16 |
IL145568A (en) | 2007-09-20 |
PL195529B1 (pl) | 2007-09-28 |
HUP0200391A3 (en) | 2002-11-28 |
AU772421B2 (en) | 2004-04-29 |
AR023130A1 (es) | 2002-09-04 |
CA2366926A1 (en) | 2000-09-28 |
CZ20013411A3 (cs) | 2002-04-17 |
GB9906715D0 (en) | 1999-05-19 |
US6521644B1 (en) | 2003-02-18 |
AU3318600A (en) | 2000-10-09 |
EP1171121B1 (en) | 2005-06-15 |
PL350796A1 (en) | 2003-02-10 |
KR20010108389A (ko) | 2001-12-07 |
UA73115C2 (en) | 2005-06-15 |
WO2000056297A3 (en) | 2001-01-25 |
NO20014608D0 (no) | 2001-09-21 |
HK1048589A1 (zh) | 2003-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200102648T2 (tr) | Büyümeyi destekleyen bileşimler | |
FI962154A (fi) | Koostumus terapeuttisten tuotteiden in vivo valmistusta varten | |
IS4083A (is) | Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja | |
EE200000654A (et) | Fumaarhappe derivaatide kasutamine transplantatsioonimeditsiinis | |
ATE249422T1 (de) | Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe | |
DE59905954D1 (de) | Dialkylfumarate zur behandlung von autoimmunerkrankungen | |
ATE383169T1 (de) | Komponente und zusammensetzungen zur verabreichung von wirkstoffen | |
JO2373B1 (en) | W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors | |
DE69727158D1 (de) | Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien | |
IL152659A (en) | Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer | |
SE9201628D0 (sv) | Pharmaceutical composition | |
DE50014532D1 (de) | Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz | |
ATE152628T1 (de) | Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft | |
DK1001775T3 (da) | Medikament indeholdende yohimbin og arginin beregnet til behandling af erektil dysfunktion | |
IL126235A (en) | Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use | |
MXPA03001455A (es) | Compuestos de pirazol, composiciones farmaceuticas y metodos para modular o inhibir la actividad del amiloide-beta-peptido asociado a reticulo endoplasmico y l-3-hidroxiacil-coa-deshidrogenasa. | |
DK1189627T3 (da) | Sammensætninger indeholdende opløselige former af HLA-G til behandling af inflammatoriske patologiske tilstande i huden | |
DK1185621T3 (da) | Overflade til cellekultur | |
ATE548048T1 (de) | Oncomodulin zur behandlung von neurologishen erkrankungen | |
ATE232541T1 (de) | Gallensauersälze mit physiologisch aktiven metalle und ihre verwendung zur therapeutischen behandlung | |
ATE235909T1 (de) | Biologisch kompatible und biologisch abbaubare zubereitungen enthaltend hyaluronsäure und deren derivate zur behandlung von geschwüren im verdauungsapparat | |
ATE329613T1 (de) | Wachstumhormone inhibitoren enthaltende pharmazeutische zubereitungen oder ihre biologisch aktive fragmente zur behandlung von uterinen myomas | |
BG105763A (en) | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | |
UA32146A (uk) | Спосіб оцінки ефективності лікування пародонтита |